Beijing, Sept 1, 2026 — China’s Center for Medical Device Evaluation (CMDE) released 59 draft registration and review guidelines for Class II active medical devices, opening a public comment period through Oct 8, 2026, as regulators standardize market entry requirements for powered equipment ranging from negative pressure suction devices to electronic diagnostic instruments.
Regulatory Snapshot
| Attribute | Detail |
|---|---|
| Issuer | Center for Medical Device Evaluation (CMDE), National Medical Products Administration |
| Document | 59 Guiding Principles for Registration and Review of Class II Active Medical Devices (Draft for Comments) |
| Lead guideline | Negative Pressure Source Suction Device Registration and Review Guiding Principles |
| Total guidelines | 59 |
| Product class | Class II active medical devices |
| Comment deadline | Oct 8, 2026 |
| Submission | Contact details per attached list |
Key Scope
The batch covers registration and review technical standards for 59 categories of Class II active medical devices—equipment that relies on electrical energy or other power sources rather than human or gravitational force. The lead document addresses negative pressure source suction devices, with the full portfolio spanning diverse powered medical equipment categories.
Market Impact Analysis
The simultaneous release of 59 draft guidelines represents one of CMDE’s largest standardization efforts for mid-risk active devices, creating a comprehensive regulatory roadmap for manufacturers navigating China’s Class II registration pathway. For domestic and international device makers, the consolidated guidance reduces interpretive ambiguity during application preparation, potentially shortening registration timelines by clarifying technical documentation, clinical evidence, and testing requirements.
The Oct 8 comment deadline provides a five-week window for industry feedback, suggesting regulators aim to finalize the guidelines by year-end. The focus on Class II active devices—a category that includes infusion pumps, patient monitors, and therapeutic ultrasound equipment—signals intensified scrutiny of powered devices that pose moderate risk but are produced by a fragmented supplier base.
Forward-Looking Statement
Industry analysts expect the finalized 59 guidelines to take effect in early 2027, establishing the definitive regulatory baseline for Class II active device registrations through the remainder of the decade. Manufacturers with pending applications or pipeline products in the covered categories should review the drafts closely, as final versions may introduce new testing protocols or clinical data requirements not explicitly mandated under previous informal guidance. The bulk release approach suggests CMDE is moving toward systematic catalog-wide standardization rather than reactive, product-specific rulemaking, a shift that could accelerate overall review efficiency but demands proactive compliance monitoring across broad device portfolios.-China Health Reform Pulse
Policy Source: https://www.cmde.org.cn/flfg/zdyz/zqyjg/20260901134127123.html